These changes, along with a growing number of complex products and new dosage forms, put a real burden ... the parameters with a high enough risk to merit process characterization.
In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan. Michelle Logan is vice president, ...
Walgreens has agreed to pay $100 million to settle a proposed class action lawsuit accusing it of fraudulently overcharging ...
In addition to colleges, merit aid is available in the form of scholarships sponsored by corporations, states, civic groups, philanthropic foundations, and others. These scholarships also ...
Third Quarter 2024 Highlights†Reported revenue of $339.8 million, up 7.8%Constant currency revenue* and constant currency revenue, organic* up ...
Purpose: The chemical interactions that cause drug incompatibility in solutions, with emphasis on the acid-base and ionized-nonionized forms of organic, weak, electrolyte drugs, are examined.
The anticipated impact of Merit’s acquisition of Cook Medical’s lead management portfolio on Merit’s operating and financial performance for 2024 and thereafter was disclosed in Merit’s October 30, ...
Per the Arizona 2024 General Election Publicity Pamphlet, Proposition 133 aims to change the state's constitution with ...
The Veilguard on certain sectors of social media without being overrun by people who have a vested interest in seeing the ...
Rystiggo (rozanolixizumab-noli) is a brand-name drug prescribed for generalized myasthenia gravis in certain adults. Rystiggo comes as an injection that’s given by a healthcare professional.
Erleada (apalutamide) is a brand-name drug prescribed for certain types of prostate cancer in adults. Erleada comes as a tablet that’s typically taken once per day. For these uses, Erleada may ...
Upon ingestion, the new dosage form expands in the stomach, remains there for a day, and releases drug at a constant rate. This enables improved drug therapies―especially for cancer. ZURICH ...